Improve Coverage Decisions on Telehealth and Remote Patient Monitoring
Reduce research time and identify digital health technologies that improve patient care at a lower cost of coverage by using ECRI Clinical Evidence Assessment
FDA has taken a hands-off approach to regulating wearable remote monitoring devices and smartphone medical apps. ECRI expertise can help you separate vendor hype from evidence-based performance.
Digital Health Technologies include smartphone medical apps and wearable patient monitoring devices. These technologies manage clinical care with the objective of improving patient access and outcomes while driving down the total cost of care.
With little to no barrier to entry, hundreds of thousands of remote patient monitoring devices and smartphone medical apps have flooded the market over the past few years, but many do not deliver on their promises, and few have gone through the FDA regulatory pathway.
Many payers offer patients a discount for remote patient monitoring care technologies, but as a coverage decision maker, how confident are you in the digital mobile devices and smartphone apps you are covering?
ECRI Clinical Evidence Assessment helps you identify digital health technologies that are backed by clinical evidence.